Blue Cross and Blue Shield of Texas · Zepbound and Wegovy coverage

Does Blue Cross and Blue Shield of Texas cover Zepbound or Wegovy?

Last updated

Not a standard benefit; some self-funded employer plans add it.

If it is not covered: the lowest cash prices now

  • Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Without insurance: compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Not a standard benefit; some self-funded employer plans add it. BCBSTX told providers in May 2025 that coverage of GLP-1 weight management drugs such as Wegovy and Zepbound is not a standard benefit, and only some self-funded (ASO) group plans add it as a custom benefit. In its words: "Coverage for GLP-1 weight management drugs, such as Saxenda, Wegovy and Zepbound, is not a standard benefit for members. Some ASO group plans may offer coverage for weight loss and/or weight management drugs as a custom benefit." (BCBSTX provider news, New Home Delivery Pharmacy Service to Fill Members' Injectable GLP-1 Prescriptions, bcbstx.com, May 20, 2025, read Nov 17, 2026). BCBSTX's May 2026 update for self-funded groups says plan coverage of weight-management GLP-1s is optional. In its words: "As with other GLP‑1s for weight management, plan coverage is optional with utilization management and metabolic health programs are available to drive safe and clinically appropriate use." (BCBSTX, What's New in GLP-1 Coverage, Spring 2026 (self-funded groups), bcbstx.com/producer/news/05-20-26-new-glp1-coverage-2026, read Nov 17, 2026). BCBSTX excluded the Zepbound KwikPen from coverage in 2026 (a dated change, for self-funded groups). In its words: "To give clarity across distribution channels for members, Zepbound Kwikpen , which is available only through direct‑to‑consumer pathways, has been excluded from coverage ." (BCBSTX, What's New in GLP-1 Coverage, Spring 2026 (self-funded groups), bcbstx.com/producer/news/05-20-26-new-glp1-coverage-2026, read Nov 17, 2026).

Questions

Blue Cross and Blue Shield of Texas, Zepbound and Wegovy: common questions

Does Blue Cross and Blue Shield of Texas cover Zepbound for weight loss?

Not a standard benefit; some self-funded employer plans add it. BCBSTX told providers in May 2025 that coverage of GLP-1 weight management drugs such as Wegovy and Zepbound is not a standard benefit, and only some self-funded (ASO) group plans add it as a custom benefit. In its words: "Coverage for GLP-1 weight management drugs, such as Saxenda, Wegovy and Zepbound, is not a standard benefit for members. Some ASO group plans may offer coverage for weight loss and/or weight management drugs as a custom benefit." (BCBSTX provider news, New Home Delivery Pharmacy Service to Fill Members' Injectable GLP-1 Prescriptions, bcbstx.com, May 20, 2025, read Nov 17, 2026). BCBSTX's May 2026 update for self-funded groups says plan coverage of weight-management GLP-1s is optional. In its words: "As with other GLP‑1s for weight management, plan coverage is optional with utilization management and metabolic health programs are available to drive safe and clinically appropriate use." (BCBSTX, What's New in GLP-1 Coverage, Spring 2026 (self-funded groups), bcbstx.com/producer/news/05-20-26-new-glp1-coverage-2026, read Nov 17, 2026). BCBSTX excluded the Zepbound KwikPen from coverage in 2026 (a dated change, for self-funded groups). In its words: "To give clarity across distribution channels for members, Zepbound Kwikpen , which is available only through direct‑to‑consumer pathways, has been excluded from coverage ." (BCBSTX, What's New in GLP-1 Coverage, Spring 2026 (self-funded groups), bcbstx.com/producer/news/05-20-26-new-glp1-coverage-2026, read Nov 17, 2026). Zepbound not covered: the cash price at your dose

Does Blue Cross and Blue Shield of Texas cover Wegovy for weight loss?

Not a standard benefit; some self-funded employer plans add it. BCBSTX told providers in May 2025 that coverage of GLP-1 weight management drugs such as Wegovy and Zepbound is not a standard benefit, and only some self-funded (ASO) group plans add it as a custom benefit. In its words: "Coverage for GLP-1 weight management drugs, such as Saxenda, Wegovy and Zepbound, is not a standard benefit for members. Some ASO group plans may offer coverage for weight loss and/or weight management drugs as a custom benefit." (BCBSTX provider news, New Home Delivery Pharmacy Service to Fill Members' Injectable GLP-1 Prescriptions, bcbstx.com, May 20, 2025, read Nov 17, 2026). BCBSTX's May 2026 update for self-funded groups says plan coverage of weight-management GLP-1s is optional. In its words: "As with other GLP‑1s for weight management, plan coverage is optional with utilization management and metabolic health programs are available to drive safe and clinically appropriate use." (BCBSTX, What's New in GLP-1 Coverage, Spring 2026 (self-funded groups), bcbstx.com/producer/news/05-20-26-new-glp1-coverage-2026, read Nov 17, 2026). BCBSTX excluded the Zepbound KwikPen from coverage in 2026 (a dated change, for self-funded groups). In its words: "To give clarity across distribution channels for members, Zepbound Kwikpen , which is available only through direct‑to‑consumer pathways, has been excluded from coverage ." (BCBSTX, What's New in GLP-1 Coverage, Spring 2026 (self-funded groups), bcbstx.com/producer/news/05-20-26-new-glp1-coverage-2026, read Nov 17, 2026). Wegovy not covered: the cash price at your dose

What do Zepbound and Wegovy cost if Blue Cross and Blue Shield of Texas does not cover them?

Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 11, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked Nov 11, 2026 on pharmacy.amazon.com and novocare.com. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership); compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership). Every GLP-1's cash price without insurance

Does Medicaid cover Zepbound or Wegovy?

It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a plan covers is decided by the plan and the employer or program behind it, and changes; check your own plan's drug list before you rely on this. This page reports the insurer's own published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.